STAAR SURGICAL CO — Director's Dealing 2020

Aug 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-08-10

Reporting Person: Hayashida Jon K. (VP, Global Clinical, Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-10	Common Stock	M	16206	$9.30	Acquired	27000	Direct
2020-08-10	Common Stock	M	5822	$7.52	Acquired	32822	Direct
2020-08-10	Common Stock	M	11574	$8.64	Acquired	44396	Direct
2020-08-10	Common Stock	M	8000	$16.15	Acquired	52396	Direct
2020-08-10	Common Stock	S	41602	$51.22	Disposed	10794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-10	Common Stock Options	$9.30	M	16206	Disposed	2027-03-20	Common Stock (16206)	Direct
2020-08-10	Common Stock Options	$7.52	M	5822	Disposed	2026-03-17	Common Stock (5822)	Direct
2020-08-10	Common Stock Options	$8.64	M	11574	Disposed	2025-07-26	Common Stock (11574)	Direct
2020-08-10	Common Stock Options	$16.15	M	8000	Disposed	2028-03-14	Common Stock (8000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.20 to $53.10, inclusive.